These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30213303)

  • 41. Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism.
    Wiersinga W; Žarković M; Bartalena L; Donati S; Perros P; Okosieme O; Morris D; Fichter N; Lareida J; von Arx G; Daumerie C; Burlacu MC; Kahaly G; Pitz S; Beleslin B; Ćirić J; Ayvaz G; Konuk O; Törüner FB; Salvi M; Covelli D; Curro N; Hegedüs L; Brix T;
    Eur J Endocrinol; 2018 Jun; 178(6):635-643. PubMed ID: 29650691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves' disease: the impact of DRB1*07.
    Kula D; Bednarczuk T; Jurecka-Lubieniecka B; Polanska J; Hasse-Lazar K; Jarzab M; Steinhof-Radwanska K; Hejduk B; Zebracka J; Kurylowicz A; Bar-Andziak E; Stechly T; Pawlaczek A; Gubala E; Krawczyk A; Szpak-Ulczok S; Nauman J; Jarzab B
    Thyroid; 2006 May; 16(5):447-53. PubMed ID: 16756466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The full length and splice variant thyrotropin receptor is expressed exclusively in skeletal muscle of extraocular origin: a link to the pathogenesis of Graves' ophthalmopathy.
    Major BJ; Cures A; Frauman AG
    Biochem Biophys Res Commun; 1997 Jan; 230(3):493-6. PubMed ID: 9015347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unilateral optic neuropathy as the initial manifestation of euthyroid Graves' disease.
    Arslan E; Yavaşoğlu I; Cildağ BM; Kocatürk T
    Intern Med; 2009; 48(22):1993-4. PubMed ID: 19915303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females.
    Cuddihy RM; Dutton CM; Bahn RS
    Thyroid; 1995 Apr; 5(2):89-95. PubMed ID: 7544179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of Human Leukocyte Antigens Class I and II with Graves' Disease in Iranian Population.
    Mehraji Z; Farazmand A; Esteghamati A; Noshad S; Sadr M; Amirzargar S; Yekaninejad MS; Amirzargar A
    Iran J Immunol; 2017 Sep; 14(3):223-230. PubMed ID: 28919585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of major histocompatibility complex alleles in the susceptibility of Brazilian patients to develop the myogenic type of Graves' orbitopathy.
    Akaishi PM; Cruz AA; Silva FL; Rodrigues Mde L; Maciel LM; Donadi EA
    Thyroid; 2008 Apr; 18(4):443-7. PubMed ID: 18352820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Genetic and environmental factors in Graves disease. A review].
    Brix TH; Kyvik KO; Hegedüs L
    Ugeskr Laeger; 1998 Jan; 160(5):616-21. PubMed ID: 9470466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Graves' ophthalmopathy and atrophic thyroiditis: a case report.
    Tamagno G; De Carlo E; Betterle C; Murialdo G
    J Endocrinol Invest; 2004 Feb; 27(2):163-6. PubMed ID: 15129812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum selenium status in Graves' disease with and without orbitopathy: a case-control study.
    Khong JJ; Goldstein RF; Sanders KM; Schneider H; Pope J; Burdon KP; Craig JE; Ebeling PR
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):905-10. PubMed ID: 24372054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between a C/T polymorphism in exon 33 of the thyroglobulin gene is associated with relapse of Graves' hyperthyroidism after antithyroid withdrawal in Taiwanese.
    Hsiao JY; Hsieh MC; Tien KJ; Hsu SC; Shin SJ; Lin SR
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3197-201. PubMed ID: 17550957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Polymorphism of the 52 triplet gene (nucleotide 253) of the TSH receptor in Basedow-Graves patients and in healthy controls].
    Kaczur V; Szalai C; Falus A; Nagy Z; Krajczár G; Balázs C
    Orv Hetil; 1997 Jun; 138(25):1625-8. PubMed ID: 9265143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
    Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
    Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M; Bingoye F; Chung F; Wall JR
    J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of Graves' ophthalmopathy by radiotherapy: A literature review.
    Beige A; Boustani J; Bouillet B; Truc G
    Cancer Radiother; 2024 Jun; 28(3):282-289. PubMed ID: 38906800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolated primary amyloidosis of the inferior rectus muscle mimicking Graves' orbitopathy.
    Monteiro ML; Gonçalves AC; Bezerra AM
    Einstein (Sao Paulo); 2016; 14(4):553-556. PubMed ID: 28076605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sinonasal abnormalities in patients with Graves' orbitopathy.
    Soler ZM; Platt MP; Leung MK; Mong S; Metson R
    Laryngoscope; 2011 Mar; 121(3):656-60. PubMed ID: 21344449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural history of graves' orbitopathy after treatment.
    Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
    Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W; Man N; Li YS; Shan ZY; Teng WP
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.
    Wiersinga WM
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):134-142. PubMed ID: 27346786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.